Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-22-010457

Chief Financial Officer acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Graham Juan Chief Financial Officer 2022-02-14 Grant or award +22,500 58,900 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Graham Juan Chief Financial Officer 2022-02-14 Grant or award · Stock Option (Right to Buy) +37,500 37,500 D: show line 2 in the form
Loading xslF345X03/doc4.xml…